Patent details

Basic Information

Publication number:

EP1819323

PCT Application Number:

PCT/US/2005/043675

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP058527904

PCT Publication Number:

WO/2006/060681

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT

French Title of Invention:

COMPOSITION PHARMACEUTIQUE RENFERMANT UN AGENT D'ANTI-NUCLEATION

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT ANTI-KEIMBILDNER

SPC Number:

Dates

Filing date:

02/12/2005

Grant date:

16/11/2016

EP Publication Date:

16/11/2016

PCT Publication Date:

08/06/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/08/2007

EP B1 Publication Date:

16/11/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/12/2016

Expiration date:

02/12/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

02/12/2005

 

 

Name:

Merck Sharp & Dohme Corp.

Address:

126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:

ARTINO Laura, M.

Address:

United States (US)

2

Name:

ZHU Honggang

Address:

United States (US)

3

Name:

CRUANES Maria, T.

Address:

United States (US)

4

Name:

XU Wei

Address:

United States (US)

Priority

Priority Number:

632859 P

Priority Date:

03/12/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/20;

Publication

European Patent Bulletin

Issue number:

201738

Publication date:

20/09/2017

Description:

Opposition procedure started

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages